GlassScriptPhysician profile
Amy Chandler
NPI 1205266723
$2,239.32
in general payments reported to CMS, 2019-2025
21 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $547 · 2022: $452 · 2023: $535 · 2024: $450 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $430.77 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Mallinckrodt Hospital Products INC. | $257.67 | 2022-2025 | Acthar, Terlivaz |
| Actelion Pharmaceuticals US, INC. | $253.66 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.43 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $172.39 | 2021-2025 | Glassia |
| Genzyme Corporation | $161.92 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $124.91 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $82.74 | 2021-2025 | Tyvaso, Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $69.93 | 2021-2024 | |
| Harmony Biosciences LLC | $69.90 | 2022-2023 | Wakix |
| Glaxosmithkline, LLC. | $66.89 | 2021 | |
| Baxter Healthcare | $65.35 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Fluid Systems - Premix Drugs |
| Philips North America LLC | $57.34 | 2021-2022 | |
| Pfizer INC. | $46.88 | 2022-2024 | |
| Pharming Healthcare, INC. | $40.40 | 2023 | Ruconest |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $31.68 | 2021 | |
| Amgen INC. | $28.61 | 2024 | Tezspire |
| Axsome Therapeutics, INC. | $20.98 | 2023 | Sunosi |
| Jazz Pharmaceuticals INC. | $17.33 | 2021 | |
| Resmed Corp | $16.78 | 2023 | |
| 3b Medical, INC. | $6.76 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.